Affiliation:
1. Department of Cardiology, Xing’an League People’s Hospital, No. 66 Hanshan West Street, Ulan Hot, Xing’an League, Inner Mongolia 137400, P. R. China
Abstract
Myocardial infarction (MI) is associated with high rates of death and disability, and is the main cause of death due to cardiovascular disease and the most frequent cause of death in the developed world. Recent studies have shown that, in addition to traditional risk factors, such as hypertension, diabetes, hyperlipidemia, obesity, smoking and the environment, the gut microbiota plays an important role in MI development and progression. The discovery of an enteric-cardioid axis provides a new route to examine the complex mechanism of MI and has become a research hotspot in recent years. Experiments have suggested that probiotics decrease ischemia/reperfusion injury and inflammation, regulate lipid metabolism and decrease the myocardial infarction area. In this review, we discuss the relationship between probiotics and MI as well as potential underlying mechanisms, to provide new ideas for the prevention and treatment of MI.
Reference82 articles.
1. Heart disease and stroke statistics-2015 update: a report from the American Heart Association;D Mozaffarian;Circulation,2015
2. A gut feeling about thrombosis;H Tilg;N Engl J Med,2016
3. Gut microbiota in cardiovascular health and disease;WH Tang;Circ Res,2017
4. The intriguing link between the intestinal microbiota and cardiovascular disease;G Lippi;Semin Thromb Hemost,2017
5. Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics;JL Griffin;Circ Cardiovasc Genet,2015
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献